Investment analysts at Citigroup began coverage on shares of Avidity Biosciences (NASDAQ:RNA – Get Free Report) in a research ...

BMO Capital Markets assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research note issued to ...

Classification of Genetic Disorders and Familial Diseases: Molecular pathology performed for cystic fibrosis, thalassemia, ...

Biomolecular condensates are shifting blobs in our cells that organize cellular matter. They are distinct molecular ...

Misinformation about vaccines has swirled online since US President Donald Trump appointed Robert F. Kennedy Jr. – who has ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

Once considered a lost species, this carnivorous marsupial, officially known as the thylacine, could soon make a comeback ...

One famous experiment conducted in 1952 by American chemists Stanley Miller and Harold Urey provided a possible explanation: ...

Researchers from Stanford University believe their new theory debunks the idea that a massive lightning strike in our ...

KRRO-110 is the first RNA editing development candidate from Korro's proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on ...

The cutting-edge technology used in COVID-19 shots may lead to new treatments for other diseases. But some conservatives are ...